Denosumab: A New Treatment for Osteoporosis

    loading  Checking for direct PDF access through Ovid



Denosumab, a human antibody, effectively increases bone mineral density in postmenopausal women.


Miller PD, et al. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial. Bone 2008;43:222-229.

Related Topics

    loading  Loading Related Articles